510(K) CLEARANCES 67 ▼8RECALLS POSTED 26CLASS I 2PMA DECISIONS 40 ▼14WEEK ENDING / FDA DATA AS OF
Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1431-2017Class II

Merge PACS software. The firm name on the label is Merge Healthcare

Merge Healthcare Incorporated / initiated 2016-04-04 / Terminated / root cause: software

Merge Healthcare, Inc. began a recall of Merge PACS software. The firm name on the label is Merge Healthcare on . FDA classified it as Class II and gives the reason as "Studies that have QC, PDE, or HL7 ADT updates applied may fail to propagate via telmed protocol to the destination server and may fail to import on the destination server". As of , the recall status on record is Terminated, and MDM tags the root cause as software.

Recall record

Recall number
Z-1431-2017
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Merge Healthcare Incorporated
Product
Merge PACS software. The firm name on the label is Merge Healthcare.
Product code
LLZ System, Image Processing, Radiological
Reason for recall
Studies that have QC, PDE, or HL7 ADT updates applied may fail to propagate via telmed protocol to the destination server and may fail to import on the destination server.
Root cause tag
software
FDA root cause
Software design
Action
Merge sent an Urgent: Medical Device Recall letter dated March 28, 2016, to all affected customers via email the week of April 4, 2016. If no email address was available, the letters were issued via certified mail. A letter dated February 21, 2017 , was issued was also issued via email or certified mail. The letter notifies the customer of the issue, informs them not receiving updated demographics or image content may result in delay in diagnosis or treatment of the patient or misdiagnosis, and they should be aware of the workaround. The customer is also notified a fix is not yet available, however, the recalling firm is working on correcting the issue and will inform them once a fix is made available. The notification instructs the customer to pass the information onto all other users, as well as any downstream customers if it was further distributed. The notification also informs the customer their response is required using the enclosed form and the return addressed envelope. The response form asks, in part, if they understand the workaround and are they interested in accepting the fix. If they decline the fix, they are asked to provide the reason why. The response was required no later than April 18, 2016. A second letter was issued dated February 21, 2017,via email or certified mail if no email address was available. The letter notified customers a fix was now available and also contained the same information and response form as the first letter. The letter informed the customer a response was required 15 calendar days after receipt of the letter. The recalling firm reported emails will be tracked for delivery confirmation and the letters will be tracked for delivery by USPS certified services. For further questions, please call (877) 741-5369.
Quantity in commerce
248 sites potentially have the affected versions
Distribution
USA (nationwide ) Distribution was made to medical facilities. Internationally to Canada. There was no government or military distribution.
Product codes and lots
Versions 6.6.1, 6.6.1.1, 6.6.2, 6.6.2.1, 6.6.2.2, 7.0, and 7.0.1

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1431-2017
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1431-2017Class IITerminatedVoluntary: Firm initiated